691856-35-6 Usage
Description
5-cyclopropyl-2-(4-fluorophenyl)-N-methyl-6-(methylsulfonamido)benzofuran-3-carboxamide is a chemical compound that belongs to the benzofuran class. It is a derivative of N-methyl-6-(methylsulfonamido)benzofuran-3-carboxamide, and it contains a cyclopropyl, fluorophenyl, and N-methyl groups. 5-cyclopropyl-2-(4-fluorophenyl)-N-methyl-6-(methylsulfonamido)benzofuran-3-carboxamide may have potential pharmacological or biological activities due to its structural characteristics.
Uses
Used in Pharmaceutical Development:
5-cyclopropyl-2-(4-fluorophenyl)-N-methyl-6-(methylsulfonamido)benzofuran-3-carboxamide is used as a potential candidate for the development of pharmaceutical drugs for various medical purposes. Its unique structural features may contribute to its pharmacological or biological activities, making it a promising compound for further research and testing.
However, it is important to note that the specific applications and industries for this compound have not been provided in the materials. Further research and testing are needed to fully understand its properties and potential applications in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 691856-35-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,9,1,8,5 and 6 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 691856-35:
(8*6)+(7*9)+(6*1)+(5*8)+(4*5)+(3*6)+(2*3)+(1*5)=206
206 % 10 = 6
So 691856-35-6 is a valid CAS Registry Number.
691856-35-6Relevant articles and documents
INHIBITORS OF HEPATITIS C VIRUS POLYMERASE
-
, (2016/10/11)
The present invention provides, among other things, compounds represented by the general Formula I: (I) and pharmaceutically acceptable salts thereof, wherein L and A (and further substituents) are as defined in classes and subclasses herein and compositions (e.g., pharmaceutical compositions) comprising such compounds, which compounds are useful as inhibitors of hepatitis C virus polymerase, and thus are useful, for example, as medicaments for the treatment of HCV infection.
BENZOFURAN COMPOUNDS FOR THE TREATMENT OF HEPATITIS C VIRUS INFECTIONS
-
, (2013/03/26)
The present invention features compounds of formula (I) and salts thereof, pharmaceutical compositions comprising said compounds, and uses of such compounds in treating or preventing viral infections, such as HCV infections, and diseases associated with such infections.
6-SUBSTITUTED BENZOFURAN COMPOUNDS TO TREAT INFECTION WITH HEPATITIS C VIRUS
-
Page/Page column 23, (2010/01/29)
Compounds of following formula (I); wherein R1, R2, R3, R4, R5, and R6 are as defined herein, including all crystalline forms and pharmaceutically acceptable salts thereof, which are useful in pharmaceutical formulations for the treatment or prevention of
